Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors

NCT00636545 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Oblimersen (Genasense)
DRUG: Oblimersen (Genasense)

Sponsor

Genta Incorporated